Our Company

1-10 of 10

Benefits Perspectives: Private exchanges: The future for large plan sponsors or a passing fad?12 February 2014 - By Greg J. Herrle and Paul R. Houchens and Troy M. Filipek - Article

Key issues for large plan sponsors that are evaluating a private exchange for their active employees.

Should your company's medical benefits be insured through a captive insurance company?06 July 2011 - By Kevin Fitzgerald and Michael Davis and Troy M. Filipek and Travis J. Grulkowski - Article
Covering all medical benefits through a captive may result in higher costs and larger administrative burdens.Pharmacy benefit management: Pros and cons of various approaches18 May 2011 - By Thomas D. Snook and Troy M. Filipek - Article
This paper examines pricing models, distribution models, and other factors that determine the cost and value of PBM services.It's time for plan sponsors to reassess their options under Part D04 October 2010 - By Troy M. Filipek and - Article
Milliman outlines the significant changes to Medicare prescription drug coverage under healthcare reform.Coming to grips with reform and its impact on prescription drug coverage01 August 2010 - By Brian N. Anderson and Troy M. Filipek - Article
Healthcare reform is affecting pharmacy benefits, and some of the most significant changes may come in the next 12 months.Healthcare reform and pharmacy benefits04 May 2010 - By Brian N. Anderson and Troy M. Filipek - Article
Reform legislation will bring new transparency to PBM contracts and will have other implications for pharmacy benefits.Healthcare reform and Medicare Part D04 May 2010 - By Troy M. Filipek and Brian N. Anderson - Article
"Healthcare reform will close the "donut hole" and usher in other significant changes to Medicare Part D."The impact of healthcare reform on Medicare Part D14 August 2009 - By Troy M. Filipek - Article

While Medicare Part D has not been a primary focus of healthcare reform efforts, there are a number of reform proposals swirling around the prescription drug program. This healthcare reform briefing paper examines the Part D related reform proposals on

Case study: Plan sponsors options under Part D16 March 2009 - By Troy M. Filipek and Charles Morency - Article

Milliman was engaged by two plan sponsors to evaluate their options and help them decide on optimal strategies for providing retiree prescription drug coverage in conjunction with Medicare.

PBM transparency could be inevitable01 February 2009 - By Troy M. Filipek - Article

The pharmacy benefit management (PBM) industry has come under intense scrutiny to become more transparent in its contracts with health plans and employers. Some PBMs have embraced transparency and see it as an inevitable shift in how pharmacy benefits are


  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman